Do you want to read an article? Please log in or register.
The impact of sensitization patterns on COPD severity and exacerbations: Insights from a case-control and longitudinal study
COPD
RECOMMENDED
Related content
COPD
Mortality and exacerbation risk according to GOLD and STAR severity stages of COPD: a 5-year multicenter prospective cohort study
Sci Rep
Ogata H, Tsubouchi K, Takano T, Ichiki K, Torii R, Takata S, Nakagaki N, Yoshida M, Kitasato Y, Tobino K, Harada E, Wataya H, Ishii H, Maeyama T, Kawasaki M, Fujita M, Yatera K, Zaizen Y, Nakanishi Y, Okamoto I
doi: 10.1038/s41598-025-05033-w
RECOMMENDED
Further Publications
Benefits of budesonide/glycopyrronium/formoterol fumarate dihydrate on lung function and exacerbations of COPD: a post-hoc analysis of the KRONOS study by blood eosinophil level and exacerbation history
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Respir Res
Muro S, Kawayama T, Sugiura H, Seki M, Duncan EA, Bowen K, Marshall J, Megally A, Patel M
doi: 10.1186/s12931-024-02918-8
RECOMMENDED
COPD
Dual-task performance and balance in patients with severe COPD: a cross-sectional study
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Ther Adv Respir Dis
Alexandru Florian C, Camelia Corina P, Adelina M, Vlad C, Roxana Ramona O, Emil Robert S, Cristian O
doi: 10.1177/17534666241287302
ERS 2024
Asthma
BEHAVE: Benralizumab reduces exacerbations and improves asthma control in real-world patients with severe asthma
RECOMMENDED
AsthmaCOPD
Treating eosinophilic exacerbations of asthma and COPD with benralizumab (ABRA): a double-blind, double-dummy, active placebo-controlled randomised trial
★ 3
Recommended by
Dr Martin Frey, Faculty Member
★ 3
Recommended by
Dr Marcus Hesse, Faculty Member
Lancet Respir Med
Ramakrishnan S, Russell REK, Mahmood HR, Krassowska K, Melhorn J, Mwasuku C, Pavord ID, Bermejo-Sanchez L, Howell I, Mahdi M, Peterson S, Bengtsson T, Bafadhel M
doi: 10.1016/S2213-2600(24)00299-6
RECOMMENDED
Asthma
The relationship between asthma and suggested alcohol dependence and heavy alcohol use in the Cooper Center longitudinal study: The role of depressive symptom severity
★ 1
Recommended by
Dr Martin Frey, Faculty Member
J Affect Disord
Agarwal CD, Shuval K, Li Q, DeFina LF, Barlow CE, Khan DA, Brown ES
doi: 10.1016/j.jad.2024.11.004
Pneumonia
Euthyroid sick syndrome predicts the risk of ischemic stroke-associated pneumonia in the acute stage of ischemic stroke: a nested case-control study
Front Endocrinol (Lausanne)
Yu S, Yan J, Logan R, Tang WT, Ye JN, Feng HX, Wang MX, Xu QR, Jiang XL, Lin HY, Wu GH, Gui Q, Duan TT
doi: 10.3389/fendo.2024.1438700
RECOMMENDED
COPD
Mirtazapine to alleviate severe breathlessness in patients with COPD or interstitial lung diseases (BETTER-B): an international, multicentre, double-blind, randomised, placebo-controlled, phase 3 mixed-method trial
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Lancet Respir Med
Higginson IJ, Brown ST, Oluyase AO, May P, Maddocks M, Costantini M, Bajwah S, Normand C, Bausewein C, Simon ST, Ryan K, Currow DC, Johnson MJ, Hart SP, Mather H, Krajnik M, Tanzi S, Ghirotto L, Bolton CE, Janowiak P, Turola E, Jolley CJ, Murden G, Wilcock A, Farsides B, Brown JM, BETTER-B consortium
doi: 10.1016/S2213-2600(24)00187-5
RECOMMENDED
COPD
CRP, Fibrinogen, White Blood Cells, and Blood Cell Indices as Prognostic Biomarkers of Future COPD Exacerbation Frequency: The TIE Cohort Study
★ 2
Recommended by
Dr Martin Frey, Faculty Member
J Clin Med
Ellingsen J, Janson C, Bröms K, Hårdstedt M, Högman M, Lisspers K, Palm A, Ställberg B, Malinovschi A
doi: 10.3390/jcm13133855